Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Reboot Study: A Single Group, Open Label Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

NCT07017686 is registered in ClinicalTrials.gov with The Bionics Institute of Australia as lead sponsor.

NCT NCT07017686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07017686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Reboot Study: A Single Group, Open Label Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis
Lead sponsor
The Bionics Institute of Australia
Phase
Not applicable
Overall status
Recruiting
Start date
August 11, 2026
Completion date
December 31, 2031
Enrollment
5 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid